Torrent Pharmaceuticals Limited Announces Resignation of Hitesh Maheshwari, Executive Director (Product Development), Designated as Senior Management Personnel
September 30, 2023 at 03:03 pm
Share
Torrent Pharmaceuticals Limited announced that Hitesh Maheshwari, Executive Director (Product Development), designated as Senior Management Personnel of the Company has tendered his resignation effective from close of business hours on 30 September 2023.
Torrent Pharmaceuticals Limited is an India-based pharmaceutical company. The Company is focused on various therapeutic segments, such as cardiovascular (CV), central nervous system (CNS), gastrointestinal (GI), vitamins minerals nutrients (VMN), anti-diabetes (AD), pain, gynecology, and dermatology. The Company is engaged in research, development, manufacturing, marketing and distribution of branded and generic pharmaceutical formulations in India and internationally. Its pediatric product brands include Tedibar, Atogla, Spoo and B4 Nappi. Its acne/facecare products brands include Clinmiskin, ACNEMOIST, TRACNILO and fash. The Company's hair/scalp care products brands include Proanagen, Perlice, Permite and NOSKURF. Its manufacturing facilities are located in the states of Gujarat, Himachal Pradesh, Madhya Pradesh, Andhra Pradesh and Sikkim. The Company's primary channel of distribution is through the wholesale drug distributors, stockiest and retail pharmacies.